Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Ashwood

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Drug Targets. CNS and Neurological Disorders|April 29, 2005
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersA Richard Green, Tim Ashwood
Trends in Pharmacological Sciences|August 14, 2003
Animal models of stroke: do they have value for discovering neuroprotective agents?A Richard Green, Tomas Odergren, Tim Ashwood
Journal of Alzheimer'S Disease : JAD|January 25, 2011
Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding studyLutz Frölich, Tim Ashwood, Jonas Nilsson, et al.
Pharmacology & Therapeutics|December 4, 2003
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059A Richard Green, Tim Ashwood, Tomas Odergren, et al.
Archives of Neurology|November 10, 2004
Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokesPatrick Lyden, Lennart Claesson, Suzanne Havstad, et al.
British Journal of Clinical Pharmacology|August 5, 2003
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patientsPer-Henrik Zingmark, Marianne Ekblom, Tomas Odergren, et al.
Brain Research|February 2, 2006
Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemiaA Richard Green, Kerstin Lanbeck-Vallén, Tim Ashwood, et al.
Critical Care Medicine|January 7, 2004
Early impairment in consciousness predicts mortality after hemispheric ischemic strokeBrett L Cucchiara, Scott E Kasner, David A Wolk, et al.
Stroke|February 26, 2011
Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measureNishant K Mishra, Ashfaq Shuaib, Patrick Lyden, et al.
The New England Journal of Medicine|August 10, 2007
NXY-059 for the treatment of acute ischemic strokeAshfaq Shuaib, Kennedy R Lees, Patrick Lyden, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Drug Targets. CNS and Neurological Disorders|April 29, 2005
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersA Richard Green, Tim Ashwood
Trends in Pharmacological Sciences|August 14, 2003
Animal models of stroke: do they have value for discovering neuroprotective agents?A Richard Green, Tomas Odergren, Tim Ashwood
Journal of Alzheimer'S Disease : JAD|January 25, 2011
Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding studyLutz Frölich, Tim Ashwood, Jonas Nilsson, et al.
Pharmacology & Therapeutics|December 4, 2003
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059A Richard Green, Tim Ashwood, Tomas Odergren, et al.
Archives of Neurology|November 10, 2004
Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokesPatrick Lyden, Lennart Claesson, Suzanne Havstad, et al.
British Journal of Clinical Pharmacology|August 5, 2003
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patientsPer-Henrik Zingmark, Marianne Ekblom, Tomas Odergren, et al.
Brain Research|February 2, 2006
Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemiaA Richard Green, Kerstin Lanbeck-Vallén, Tim Ashwood, et al.
Critical Care Medicine|January 7, 2004
Early impairment in consciousness predicts mortality after hemispheric ischemic strokeBrett L Cucchiara, Scott E Kasner, David A Wolk, et al.
Stroke|February 26, 2011
Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measureNishant K Mishra, Ashfaq Shuaib, Patrick Lyden, et al.
The New England Journal of Medicine|August 10, 2007
NXY-059 for the treatment of acute ischemic strokeAshfaq Shuaib, Kennedy R Lees, Patrick Lyden, et al.
Pageof 2